pentoxifylline has been researched along with Anasarca in 19 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study aimed to investigate the effects of pentoxifylline (PTX) on the carrageenan (CG)-induced paw oedema and on the endogenous levels of cell enzyme and non-enzyme antioxidants in rat liver, 4 and 24 h after CG injection." | 7.76 | In vivo effects of pentoxifylline on enzyme and non-enzyme antioxidant levels in rat liver after carrageenan-induced paw inflammation. ( Alexandrova, A; Georgieva, A; Kirkova, M; Kubera, M; Mateeva, P; Vircheva, S; Zamfirova, R, 2010) |
| "We investigated the effects of iloprost and pentoxifylline on skeletal muscle ischemia-reperfusion injury in a rabbit model." | 7.74 | Iloprost and pentoxifylline attenuate ischemia-reperfusion injury in skeletal muscle in rabbit model. ( Aksun, M; Bozok, S; Emrecan, B; Gürbüz, A; Ozcan, AV; Saçar, M; Tulukoğlu, E; Yağdi, S, 2008) |
| "Pentoxifylline is a methylxanthine derivative with rheologic and marked anti-inflammatory properties and inhibits the production of proinflammatory cytokines." | 5.31 | Pentoxifylline ameliorates cerulein-induced pancreatitis in rats: role of glutathione and nitric oxide. ( Calvete, J; Camps, B; Cerdá, M; de La Asunción, JG; Gómez-Cambronero, L; Mann, GE; Pallardó, FV; Pellín, A; Sastre, J; Sweiry, JH; Viña, J, 2000) |
| "The present study aimed to investigate the effects of pentoxifylline (PTX) on the carrageenan (CG)-induced paw oedema and on the endogenous levels of cell enzyme and non-enzyme antioxidants in rat liver, 4 and 24 h after CG injection." | 3.76 | In vivo effects of pentoxifylline on enzyme and non-enzyme antioxidant levels in rat liver after carrageenan-induced paw inflammation. ( Alexandrova, A; Georgieva, A; Kirkova, M; Kubera, M; Mateeva, P; Vircheva, S; Zamfirova, R, 2010) |
| "We investigated the effects of iloprost and pentoxifylline on skeletal muscle ischemia-reperfusion injury in a rabbit model." | 3.74 | Iloprost and pentoxifylline attenuate ischemia-reperfusion injury in skeletal muscle in rabbit model. ( Aksun, M; Bozok, S; Emrecan, B; Gürbüz, A; Ozcan, AV; Saçar, M; Tulukoğlu, E; Yağdi, S, 2008) |
| "Valproic acid (VA) is a major antiepileptic drug, used for several therapeutic indications." | 1.39 | Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties. ( Correia, AO; da Graça Naffah-Mazzacorati, M; de Castro Brito, GA; de Oliveira Gonçalves, D; Félix, FH; Leal, LK; Neves, KR; Santos Cerqueira, G; Siqueira, RM; Viana, GS; Ximenes, JC, 2013) |
| "Oral mucositis is a frequent side-effect of cancer therapy." | 1.33 | Effects of the tumour necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters. ( Augusto, RF; Brito, GA; Cunha, FQ; Falcão, BA; Leitão, BT; Lima, V; Rebouças, CG; Ribeiro, RA; Souza, ML, 2005) |
| "2% at 1 and 2h after dosing (P<0." | 1.32 | The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat. ( Abdel-Salam, OM; Arbid, MS; Baiuomy, AR; El-Shenawy, SM, 2003) |
| "Pentoxifylline is a methylxanthine derivative with rheologic and marked anti-inflammatory properties and inhibits the production of proinflammatory cytokines." | 1.31 | Pentoxifylline ameliorates cerulein-induced pancreatitis in rats: role of glutathione and nitric oxide. ( Calvete, J; Camps, B; Cerdá, M; de La Asunción, JG; Gómez-Cambronero, L; Mann, GE; Pallardó, FV; Pellín, A; Sastre, J; Sweiry, JH; Viña, J, 2000) |
| " In the present study, we investigated the oedematogenic activity of both toxins, characterizing the time-course and dose-response of this pro-inflammatory event." | 1.31 | The effect of tumour necrosis factor (TNF) inhibitors in Clostridium difficile toxin-induced paw oedema and neutrophil migration. ( Carneiro-Filho, BA; Lima, AA; Ribeiro, RA; Souza, ML, 2001) |
| "Pentoxifylline (PF) has been shown to increase tissue oxygen tension." | 1.27 | Protective effect of pentoxifylline on gastric mucosa. ( Bui, HX; Sarfeh, IJ; Soliman, MH; Tarnawski, A; Tominaga, G; Waxman, K, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 10 (52.63) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ximenes, JC | 1 |
| de Oliveira Gonçalves, D | 1 |
| Siqueira, RM | 1 |
| Neves, KR | 1 |
| Santos Cerqueira, G | 1 |
| Correia, AO | 1 |
| Félix, FH | 1 |
| Leal, LK | 1 |
| de Castro Brito, GA | 1 |
| da Graça Naffah-Mazzacorati, M | 1 |
| Viana, GS | 1 |
| Cavalcanti, AL | 1 |
| Reis, MY | 1 |
| Silva, GC | 1 |
| Ramalho, ÍM | 1 |
| Guimarães, GP | 1 |
| Silva, JA | 1 |
| Saraiva, KL | 1 |
| Damasceno, BP | 1 |
| Emrecan, B | 1 |
| Tulukoğlu, E | 1 |
| Bozok, S | 1 |
| Aksun, M | 1 |
| Yağdi, S | 1 |
| Ozcan, AV | 1 |
| Saçar, M | 1 |
| Gürbüz, A | 1 |
| Vircheva, S | 1 |
| Alexandrova, A | 1 |
| Georgieva, A | 1 |
| Mateeva, P | 1 |
| Zamfirova, R | 1 |
| Kubera, M | 1 |
| Kirkova, M | 1 |
| Szabolcsi, O | 1 |
| Nagy-Toldi, A | 1 |
| Zeher, M | 1 |
| Végh, J | 1 |
| Viana, CF | 1 |
| Melo, DH | 1 |
| Carneiro-Filho, BA | 2 |
| Michelin, MA | 1 |
| Brito, GA | 2 |
| Cunha, FQ | 2 |
| Lima, AA | 2 |
| Ribeiro, RA | 3 |
| Abdel-Salam, OM | 1 |
| Baiuomy, AR | 1 |
| El-Shenawy, SM | 1 |
| Arbid, MS | 1 |
| Michetti, C | 1 |
| Coimbra, R | 1 |
| Hoyt, DB | 1 |
| Loomis, W | 1 |
| Junger, W | 1 |
| Wolf, P | 1 |
| Dorazil-Dudzik, M | 1 |
| Mika, J | 1 |
| Schafer, MK | 1 |
| Li, Y | 1 |
| Obara, I | 1 |
| Wordliczek, J | 1 |
| Przewłocka, B | 1 |
| Chaves, F | 1 |
| Teixeira, CF | 1 |
| Gutiérrez, JM | 1 |
| Lima, V | 1 |
| Rebouças, CG | 1 |
| Falcão, BA | 1 |
| Augusto, RF | 1 |
| Souza, ML | 2 |
| Leitão, BT | 1 |
| Mota, MR | 1 |
| Criddle, DN | 1 |
| Alencar, NM | 1 |
| Gomes, RC | 1 |
| Meireles, AV | 1 |
| Santi-Gadelha, T | 1 |
| Gadelha, CA | 1 |
| Oliveira, CC | 1 |
| Benevides, RG | 1 |
| Cavada, BS | 1 |
| Assreuy, AM | 1 |
| Hildmann, H | 1 |
| Müller, R | 1 |
| Lehrach, F | 1 |
| Chen, YL | 1 |
| Le Vraux, V | 1 |
| Giroud, JP | 1 |
| Chauvelot-Moachon, L | 1 |
| Gómez-Cambronero, L | 1 |
| Camps, B | 1 |
| de La Asunción, JG | 1 |
| Cerdá, M | 1 |
| Pellín, A | 1 |
| Pallardó, FV | 1 |
| Calvete, J | 1 |
| Sweiry, JH | 1 |
| Mann, GE | 1 |
| Viña, J | 1 |
| Sastre, J | 1 |
| Harada, H | 1 |
| Ishizaka, A | 1 |
| Yonemaru, M | 1 |
| Mallick, AA | 1 |
| Hatherill, JR | 1 |
| Zheng, H | 1 |
| Lilly, CM | 1 |
| O'Hanley, PT | 1 |
| Raffin, TA | 1 |
| Tominaga, G | 1 |
| Waxman, K | 1 |
| Soliman, MH | 1 |
| Sarfeh, IJ | 1 |
| Bui, HX | 1 |
| Tarnawski, A | 1 |
1 review available for pentoxifylline and Anasarca
| Article | Year |
|---|---|
Haemorheology and cerebrovascular disease: multifunctional approach with pentoxifylline.
Topics: Cerebrovascular Circulation; Cerebrovascular Disorders; Edema; Humans; Oxygen Consumption; Pentoxify | 1981 |
18 other studies available for pentoxifylline and Anasarca
| Article | Year |
|---|---|
Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Anticonvulsants; Butyric Acid; Carrageenan; Drug Syne | 2013 |
Microemulsion for topical application of pentoxifylline: In vitro release and in vivo evaluation.
Topics: Administration, Cutaneous; Animals; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Liberati | 2016 |
Iloprost and pentoxifylline attenuate ischemia-reperfusion injury in skeletal muscle in rabbit model.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Edema; Female; Humans; Iloprost; Male; M | 2008 |
In vivo effects of pentoxifylline on enzyme and non-enzyme antioxidant levels in rat liver after carrageenan-induced paw inflammation.
Topics: Animals; Antioxidants; Carrageenan; Edema; Free Radical Scavengers; Hindlimb; Inflammation; Liver; M | 2010 |
[Systemic sclerosis in a patient suffering from breast cancer].
Topics: Adult; Amlodipine; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Duct | 2012 |
Pro-inflammatory effects of cholera toxin: role of tumor necrosis factor alpha.
Topics: Animals; Cell Movement; Cholera Toxin; Dexamethasone; Disease Models, Animal; Dose-Response Relation | 2002 |
The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Celecoxib; Dexamethasone; Dose-Response Relationship | 2003 |
Pentoxifylline reduces acute lung injury in chronic endotoxemia.
Topics: Animals; Bronchoalveolar Lavage Fluid; CD11b Antigen; Chronic Disease; Edema; Endotoxemia; Intercell | 2003 |
The effects of local pentoxifylline and propentofylline treatment on formalin-induced pain and tumor necrosis factor-alpha messenger RNA levels in the inflamed tissue of the rat paw.
Topics: Animals; Dose-Response Relationship, Drug; Edema; Hindlimb; Inflammation; Male; Pain Measurement; Pe | 2004 |
Role of TNF-alpha, IL-1beta and IL-6 in the local tissue damage induced by Bothrops asper snake venom: an experimental assessment in mice.
Topics: Animals; Bothrops; Crotalid Venoms; Dose-Response Relationship, Drug; Edema; Hemorrhage; Interleukin | 2005 |
Effects of the tumour necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters.
Topics: Abscess; Animals; Antimetabolites, Antineoplastic; Cricetinae; Disease Models, Animal; Edema; Erythe | 2005 |
Modulation of acute inflammation by a chitin-binding lectin from Araucaria angustifolia seeds via mast cells.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Capillary Permeability; Chitin; Dose-Response Rela | 2006 |
[Postoperative treatment after ear surgery].
Topics: Adrenal Cortex Hormones; Edema; Hearing Loss, Noise-Induced; Humans; Labyrinth Diseases; Labyrinthit | 1983 |
Anti-tumor necrosis factor properties of non-peptide drugs in acute-phase responses.
Topics: Acute-Phase Reaction; Animals; Dose-Response Relationship, Drug; Edema; Fusidic Acid; Interleukin-6; | 1994 |
Pentoxifylline ameliorates cerulein-induced pancreatitis in rats: role of glutathione and nitric oxide.
Topics: Animals; Antioxidants; Ceruletide; Dose-Response Relationship, Drug; Edema; Gastrointestinal Agents; | 2000 |
The effect of tumour necrosis factor (TNF) inhibitors in Clostridium difficile toxin-induced paw oedema and neutrophil migration.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Botulinum Toxins; Botulinum Toxins, Type A; Chemot | 2001 |
The effects of aminophylline and pentoxifylline on multiple organ damage after Escherichia coli sepsis.
Topics: Albumins; Aminophylline; Animals; Blood Pressure; Bronchoalveolar Lavage Fluid; Edema; Escherichia c | 1989 |
Protective effect of pentoxifylline on gastric mucosa.
Topics: Animals; Edema; Ethanol; Gastric Mucosa; Gastrointestinal Contents; Hydrogen-Ion Concentration; Oxyg | 1988 |